(-)-epigallocatechin 3-gallate multiple interactions ISO XPO1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of XPO1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO Xpo1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of XPO1 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Xpo1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of XPO1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO XPO1 (Homo sapiens) 6480464 Estradiol results in increased expression of XPO1 mRNA CTD PMID:16514628 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Xpo1 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Xpo1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of XPO1 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of XPO1 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Xpo1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of XPO1 mRNA CTD PMID:24680724 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of XPO1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of XPO1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO XPO1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of XPO1 mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol increases expression ISO XPO1 (Homo sapiens) 6480464 bisphenol S results in increased expression of XPO1 protein CTD PMID:34186270 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO XPO1 (Homo sapiens) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XPO1 protein CTD PMID:20421341 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of XPO1 mRNA CTD PMID:21346803 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of XPO1 protein CTD PMID:33236894 acrolein multiple interactions ISO XPO1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPO1 mRNA CTD PMID:32699268 acrylamide increases expression ISO XPO1 (Homo sapiens) 6480464 Acrylamide results in increased expression of XPO1 mRNA CTD PMID:32763439 afimoxifene decreases expression ISO XPO1 (Homo sapiens) 6480464 afimoxifene results in decreased expression of XPO1 mRNA CTD PMID:16514628 aflatoxin B1 increases expression ISO Xpo1 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of XPO1 mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO XPO1 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of XPO1 mRNA CTD PMID:30928695 AICA ribonucleotide multiple interactions ISO XPO1 (Homo sapiens) 6480464 AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to XPO1 protein] more ... CTD PMID:33070465 all-trans-retinoic acid decreases expression ISO XPO1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of XPO1 mRNA CTD PMID:18614847 alpha-pinene multiple interactions ISO XPO1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPO1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of XPO1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO XPO1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of XPO1 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO XPO1 (Homo sapiens) 6480464 Arsenic Trioxide promotes the reaction [XPO1 protein binds to YWHAQ protein] CTD PMID:33070465 aurantio-obtusin decreases expression ISO Xpo1 (Mus musculus) 6480464 aurantio-obtusin results in decreased expression of XPO1 mRNA CTD PMID:34718095 benzo[a]pyrene affects methylation ISO XPO1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of XPO1 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO XPO1 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of XPO1 mRNA CTD PMID:25181051 and PMID:30816183 bisphenol A increases methylation ISO XPO1 (Homo sapiens) 6480464 bisphenol A results in increased methylation of XPO1 gene CTD PMID:31601247 bisphenol A decreases expression ISO Xpo1 (Mus musculus) 6480464 bisphenol A results in decreased expression of XPO1 mRNA CTD PMID:33221593 bisphenol A decreases expression ISO XPO1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of XPO1 protein CTD PMID:37567409 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of XPO1 mRNA CTD PMID:24136188 cadmium atom multiple interactions ISO Xpo1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPO1 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions ISO Xpo1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPO1 mRNA and XPO1 protein affects the reaction [Cadmium Chloride affects the localization of BACH1 protein] CTD PMID:14504288 and PMID:37325564 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of XPO1 mRNA CTD PMID:33453195 caffeine decreases phosphorylation ISO XPO1 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of XPO1 protein CTD PMID:35688186 calcitriol decreases expression ISO XPO1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of XPO1 mRNA CTD PMID:16847355 and PMID:18614847 cannabidiol multiple interactions ISO XPO1 (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of XPO1 protein CTD PMID:34122009 cannabidiol increases expression ISO XPO1 (Homo sapiens) 6480464 Cannabidiol results in increased expression of XPO1 mRNA CTD PMID:31801206 chloropicrin increases expression ISO XPO1 (Homo sapiens) 6480464 chloropicrin results in increased expression of XPO1 mRNA CTD PMID:26352163 chloroquine multiple interactions ISO XPO1 (Homo sapiens) 6480464 Chloroquine promotes the reaction [XPO1 protein binds to BECN1 protein] and Chloroquine promotes the reaction [XPO1 protein binds to YWHAQ protein] CTD PMID:33070465 chlorpyrifos decreases expression ISO Xpo1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of XPO1 mRNA CTD PMID:37019170 chlorpyrifos increases expression ISO Xpo1 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of XPO1 mRNA CTD PMID:34289071 ciguatoxin CTX1B affects expression ISO Xpo1 (Mus musculus) 6480464 Ciguatoxins affects the expression of XPO1 mRNA CTD PMID:18353800 clofibrate increases expression ISO Xpo1 (Mus musculus) 6480464 Clofibrate results in increased expression of XPO1 mRNA CTD PMID:17585979 copper atom increases expression EXP 6480464 Copper results in increased expression of XPO1 mRNA CTD PMID:22465980 and PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of XPO1 mRNA CTD PMID:22465980 and PMID:30556269 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of XPO1 mRNA CTD PMID:15755911 coumarin affects phosphorylation ISO XPO1 (Homo sapiens) 6480464 coumarin affects the phosphorylation of XPO1 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO Xpo1 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of XPO1 mRNA CTD PMID:29279043 Cuprizon multiple interactions ISO XPO1 (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of XPO1 protein CTD PMID:34122009 curcumin multiple interactions ISO Xpo1 (Mus musculus) 6480464 Curcumin inhibits the reaction [KRAS protein results in decreased expression of XPO1 protein] CTD PMID:21519798 diarsenic trioxide multiple interactions ISO XPO1 (Homo sapiens) 6480464 Arsenic Trioxide promotes the reaction [XPO1 protein binds to YWHAQ protein] CTD PMID:33070465 dibutyl phthalate decreases expression ISO Xpo1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of XPO1 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO XPO1 (Homo sapiens) 6480464 dicrotophos results in decreased expression of XPO1 mRNA CTD PMID:28302478 doxorubicin multiple interactions EXP 6480464 Doxorubicin promotes the reaction [MIRLET7F-2 mRNA results in decreased expression of XPO1 mRNA] more ... CTD PMID:31570982 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of XPO1 mRNA and Doxorubicin results in decreased expression of XPO1 protein CTD PMID:31570982 enzyme inhibitor multiple interactions ISO XPO1 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of XPO1 protein CTD PMID:23301498 ethanol affects expression ISO Xpo1 (Mus musculus) 6480464 Ethanol affects the expression of XPO1 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of XPO1 mRNA CTD PMID:24136188 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of XPO1 mRNA CTD PMID:21852994 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of XPO1 mRNA CTD PMID:21852994 flutamide increases expression EXP 6480464 Flutamide results in increased expression of XPO1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Xpo1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of XPO1 mRNA CTD PMID:22206623 formaldehyde multiple interactions ISO XPO1 (Homo sapiens) 6480464 Formaldehyde affects the reaction [SET protein alternative form binds to XPO1 protein] CTD PMID:36534342 fulvestrant decreases expression ISO XPO1 (Homo sapiens) 6480464 fulvestrant results in decreased expression of XPO1 mRNA CTD PMID:16514628 furan increases expression EXP 6480464 furan results in increased expression of XPO1 mRNA CTD PMID:25539665 and PMID:26194646 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of XPO1 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO XPO1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of XPO1 mRNA CTD PMID:20044591 ivermectin decreases expression ISO XPO1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of XPO1 protein CTD PMID:32959892 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of XPO1 mRNA CTD PMID:24136188 leptomycin B multiple interactions ISO Xpo1 (Mus musculus) 6480464 [leptomycin B results in decreased activity of XPO1 protein] which results in decreased export of SMAD4 protein CTD PMID:26354774 leptomycin B decreases activity ISO Xpo1 (Mus musculus) 6480464 leptomycin B results in decreased activity of XPO1 protein CTD PMID:26354774 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of XPO1 mRNA CTD PMID:24136188 menadione affects expression ISO XPO1 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of XPO1 mRNA CTD PMID:20044591 methidathion decreases expression ISO Xpo1 (Mus musculus) 6480464 methidathion results in decreased expression of XPO1 mRNA CTD PMID:34813904 methylparaben increases expression ISO XPO1 (Homo sapiens) 6480464 methylparaben results in increased expression of XPO1 mRNA CTD PMID:31745603 miconazole decreases expression ISO Xpo1 (Mus musculus) 6480464 Miconazole results in decreased expression of XPO1 mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium increases expression ISO XPO1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of XPO1 mRNA CTD PMID:24810058 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of XPO1 mRNA CTD PMID:24136188 nickel atom decreases expression ISO XPO1 (Homo sapiens) 6480464 Nickel results in decreased expression of XPO1 mRNA CTD PMID:23195993 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of XPO1 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of XPO1 mRNA CTD PMID:25729387 ozone multiple interactions ISO XPO1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO1 mRNA more ... CTD PMID:32699268 paclitaxel decreases expression ISO XPO1 (Homo sapiens) 6480464 Paclitaxel results in decreased expression of XPO1 mRNA CTD PMID:15000894 paracetamol affects expression ISO Xpo1 (Mus musculus) 6480464 Acetaminophen affects the expression of XPO1 mRNA CTD PMID:17562736 perfluorohexanesulfonic acid increases expression ISO Xpo1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of XPO1 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid multiple interactions ISO Xpo1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of XPO1 mRNA CTD PMID:36331819 phenobarbital affects expression ISO XPO1 (Homo sapiens) 6480464 Phenobarbital affects the expression of XPO1 mRNA CTD PMID:19159669 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of XPO1 mRNA CTD PMID:15215175 potassium chromate decreases expression ISO XPO1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of XPO1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO XPO1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of XPO1 mRNA CTD PMID:22079256 potassium dichromate affects expression ISO Xpo1 (Mus musculus) 6480464 Potassium Dichromate affects the expression of XPO1 mRNA CTD PMID:23608068 propiconazole increases expression ISO Xpo1 (Mus musculus) 6480464 propiconazole results in increased expression of XPO1 mRNA CTD PMID:21278054 quercetin decreases expression ISO XPO1 (Homo sapiens) 6480464 Quercetin results in decreased expression of XPO1 mRNA CTD PMID:21632981 raloxifene decreases expression ISO XPO1 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased expression of XPO1 mRNA CTD PMID:16514628 resveratrol decreases expression ISO Xpo1 (Mus musculus) 6480464 resveratrol results in decreased expression of XPO1 protein CTD PMID:25505154 sodium arsenite decreases expression ISO Xpo1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of XPO1 mRNA and sodium arsenite results in decreased expression of XPO1 protein CTD PMID:32991915 sodium arsenite multiple interactions ISO Xpo1 (Mus musculus) 6480464 [sodium arsenite binds to ID3 protein] promotes the reaction [XPO1 protein affects the localization of ID3 protein] CTD PMID:23523789 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of XPO1 mRNA CTD PMID:25993096 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide and E coli O55-B5] affects the expression of XPO1 mRNA CTD PMID:20371263 tetrachloromethane increases expression ISO Xpo1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of XPO1 mRNA CTD PMID:27339419 tetrachloromethane affects expression ISO Xpo1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of XPO1 mRNA CTD PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of XPO1 protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of XPO1 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide decreases expression ISO Xpo1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of XPO1 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of XPO1 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of XPO1 gene CTD PMID:27618143 trichostatin A affects expression ISO XPO1 (Homo sapiens) 6480464 trichostatin A affects the expression of XPO1 mRNA CTD PMID:28542535 triptonide increases expression ISO Xpo1 (Mus musculus) 6480464 triptonide results in increased expression of XPO1 mRNA CTD PMID:33045310 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of XPO1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO XPO1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of XPO1 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of XPO1 mRNA CTD PMID:23034163